Nervous System

Why brain-derived estrogen isn't enough

You blame brain fog on a lack of discipline. It's an energy deficit. Your brain is missing its chief operator, estradiol, and running on backup power.

Abstract cream-and-slate line illustration on Kokorology paper, drawn for Why brain-derived estrogen isn't enough

It's the Tuesday after a long weekend. Your inbox is a relentless scroll of demands. You sit down to write a simple email and the words will not come. You call it 'vacation brain' and reach for a third coffee, but the feeling is friction, a cognitive static you can’t seem to clear. For years, I blamed this on a lack of discipline. I was wrong. That static is the lived experience of a brain running on an energy deficit, a signal that your power supply is faltering because a key ingredient—estradiol—has gone missing.

Estradiol is your brain's chief operating officer

For decades, estradiol was filed under 'reproduction'. This administrative decision has cost women decades of cognitive health. I used to make the same mistake, dismissing it as irrelevant to my work on cognitive performance. In your brain, estradiol is a neurosteroid whose primary role is managing your entire energy budget, a function far more critical to your daily experience than its reproductive duties.

Estradiol is the hand on the dial, directing blood flow to ensure active brain regions get the oxygen and fuel they need. It fine-tunes glucose uptake, the process of getting sugar from the blood into brain cells to be used as energy. It supports neuroplasticity—the growth of new connections between neurons that underpins learning and memory—by boosting a factor called BDNF (brain-derived neurotrophic factor). When BDNF is abundant, you feel sharp. Learning a new software is frustrating but doable; you can hold a new concept in your head long enough for it to stick. When BDNF is low, you re-read the same paragraph five times and still don't know what it said. It also keeps the brain's resident immune cells, the microglia, in a calm, 'housekeeping' mode, preventing them from tipping into a pro-inflammatory state.

Think of it as the conductor of an orchestra. When the conductor is on the podium, the different sections—mood, temperature, cognition, sleep—play in time. Estradiol helps tune the instruments by modulating key neurotransmitters. It supports serotonin, which provides resilience to stress and a baseline of well-being. It promotes dopamine, which isn't just about pleasure, but the drive to seek it—the 'get up and go' that gets you out of bed for a walk. It sharpens the signal of acetylcholine, which is crucial for memory consolidation and focus. When the conductor leaves the podium during perimenopause, the signals become erratic. A drop in dopamine signalling drains the impulse to start your to-do list. The serotonin system loses its tune, making minor annoyances feel like personal attacks. With acetylcholine function faltering, you walk into a room and forget why you are there. These seemingly unrelated symptoms—brain fog, memory lapses, mood swings, hot flashes—are all signals from a single, system-wide loss of regulation.

The glucose-insulin disconnect in the menopausal brain

The brain fog is more than a vague feeling; it's a measurable energy gap. Your brain is a glucose hog, consuming about 20% of your body's total energy despite being only 2% of its weight. Estradiol is the key that opens the door for glucose to enter brain cells. When estradiol levels decline, that door gets harder to open.

Your brain becomes less sensitive to insulin, the hormone that normally shuttles glucose into cells. The result is a peculiar and frustrating paradox: you can have plenty of glucose circulating in your bloodstream, but your brain cells are starving. This state of effective starvation is called cerebral glucose hypometabolism. It shows up on a brain scan—a PET scan, specifically—as regions that have gone dim, literally using less energy than they did a few years prior.

This is the mechanism behind losing your train of thought mid-sentence, or finding that a task you used to do on autopilot now requires intense concentration. It's why the 3pm slump feels less like a gentle dip and more like falling off a cliff during perimenopause. Your brain has lost its metabolic buffer. A normal day’s demands suddenly become overwhelming because there's no reserve capacity. Any unexpected stressor—a tense meeting, a delayed train—can trigger a full-system crash because the energy supply was already on red alert. It’s also why you might find yourself craving sugar because your brain is desperately sending out an SOS for a quick, easy source of fuel it can actually use. This energy crisis forces the brain to switch to a less efficient fuel source—ketones—which it is not well-practised at using. The transition is messy, and the cognitive static you feel is the sound of the engine sputtering.

The brain's backup generator can't run the whole city

Your brain does have a local, emergency supply. It can synthesise its own estrogen from other hormones circulating in the blood. The wellness world loves this story: your body is wise, it has a backup plan. It's a comforting story that leaves out the most important part.

This local production is a backup generator, designed for acute, localised crises. It is insufficient for running the entire metropolitan grid of your brain for the thirty or forty years after menopause. Relying on this system long-term is like running a city on diesel generators: it's expensive, inefficient, and creates a lot of toxic byproducts. In the brain, these byproducts are a cascade of inflammatory molecules called cytokines.

This is not some abstract concept; it has a direct effect on your mood and cognition. That feeling of irritability, the low-grade depression, the sense that your brain is 'on fire'—that’s the felt sense of neuroinflammation. This chronic, low-grade inflammation is like a city-wide sanitation strike during a heatwave. It damages neurons, interferes with neurotransmitter signalling, and, crucially, impairs the brain's nightly cleaning service, the glymphatic system. The glymphatic system relies on the deep stages of sleep to flush out metabolic waste, including the very proteins implicated in Alzheimer's disease. When inflammation is high and sleep is fragmented by hot flashes, this cleaning process grinds to a halt. Over time, this accumulated debris, inflammatory state, and persistent energy deficit is the slow, quiet path towards neurodegenerative disease, including Alzheimer's, for which women are at a significantly higher risk.

Common Questions

But isn't hormone replacement therapy linked to cancer?

The large study that sparked this fear over 20 years ago used synthetic, oral hormones on an older population, who were often more than a decade past menopause. It was a flawed design that has unfortunately shaped a generation of medical advice. Today, the conversation is about body-identical hormones—estradiol and micronised progesterone—which have the same molecular structure as the ones your body makes. When delivered through the skin as a patch, gel, or spray, estradiol bypasses the liver, which significantly changes its risk profile, particularly for blood clots. The risk of breast cancer is complex, but the risk increase with modern HRT is small, comparable to other lifestyle factors like drinking alcohol, and is primarily associated with the type of progestogen used and duration of use.

Is it too late for me to consider HRT for my brain?

There appears to be a 'critical window' for starting hormone therapy to get the maximum neuroprotective benefit, ideally within the first 10 years after your final menstrual period. This is when the brain's estrogen receptors are still plentiful and responsive. Starting later may not provide the same degree of protection against future cognitive decline, but it can still offer significant relief from symptoms like hot flashes and sleep disruption. Eliminating these symptoms removes major disruptors of brain health in their own right, and managing them can free up considerable cognitive and metabolic resources. This is a nuanced conversation to have with a menopause-literate practitioner who understands your personal health history and the current data.

What can I do if I can't or won't take hormones?

Hormone therapy is one powerful lever, not the only one. Given that the central problem is a brain energy crisis, your job is to support the system from other angles. You can aggressively manage the inputs. This means stabilising your blood sugar to avoid the glucose spikes and crashes that your brain can no longer handle efficiently. It means using resistance training to build and maintain muscle, which acts as a storage tank for glucose and improves overall insulin sensitivity. Lifting heavy things also releases anti-inflammatory myokines, directly counteracting the neuroinflammation driven by estrogen loss. Prioritising sleep gives your glymphatic system the best chance to clear out inflammatory debris. A diet rich in polyphenols and omega-3s also helps to dial down the inflammation that the loss of estradiol permits.

Closing

Recognising the problem is the start. The next step is to take one concrete action to change the inputs to the system.

TL;DR

The brain fog of perimenopause is a brain energy crisis. Declining estradiol disrupts the brain's ability to use its primary fuel, glucose, creating a deficit that feels like cognitive static. The brain's local 'backup generator' for estrogen production cannot compensate long-term and leads to chronic neuroinflammation, increasing the risk of dementia. While timely, body-identical hormone therapy is a powerful tool for neuroprotection, aggressively managing blood sugar, building muscle through resistance training, and prioritising sleep are non-negotiable levers for protecting your cognitive future, with or without hormones.

Sources

  • Maki, P. M., & Thurston, R. C. (2020). Menopause and brain health: Hormonal changes are only part of the story. Frontiers in Neurology, 11, 562275.
  • Freeman, E. W., et al. (2015). Depression in the menopause transition: Risks in the changing hormone milieu as observed in the general population. Women's Midlife Health, 1, 2.
  • Schelbaum, E., et al. (2023). Association of Hormone Therapy With the Risk of New-Onset Dementia. JAMA Neurology, 80(12), 1279-1288.
  • Chandola, T., et al. (2008). Work stress and coronary heart disease: What are the mechanisms?. European Heart Journal, 29(5), 640–648.